Elly Marcq

Antwerpen, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells.

Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 28, 2025

Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and Recommendations.

Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and Recommendations.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 01, 2025

Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis.

Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis.

Journal: ERJ open research

Published: June 20, 2025

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.

Journal: Oncoimmunology

Published: May 29, 2025

A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice.

A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice.

Journal: Methods and protocols

Published: April 10, 2025

Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.

Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq.

Journal: Nature communications

Published: February 13, 2025

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.

Journal: Journal for immunotherapy of cancer

Published: September 08, 2024

The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.

The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.

Journal: Frontiers in toxicology

Published: January 19, 2024

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.

Journal: Journal of hematology & oncology

Published: September 22, 2023

PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomas.

PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomas.

Journal: Immunotherapy

Published: September 04, 2023

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.

Journal: Antioxidants (Basel, Switzerland)

Published: February 02, 2023

Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.

Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.

Journal: Journal of breath research

Published: December 16, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026